SEC-sourced researchBeta
BTCY
BIOTRICITY INC.
Company comparison ↗
Data passport
- CIK
- 0001630113
- Exchange
- OTC
- Business activity
- Surgical & Medical Instruments & Apparatus · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| March 2025 | 13,790,294.0000 | Jul 14, 2026 |
| March 2026 | 15,998,239.0000 | Jul 14, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| March 2026 | 15,998,239.0000 | -2,404,139.0000 | -718,955.0000 | 6,446,488.0000 | 39,408,954.0000 | Jul 14, 2026 |
| March 2025 | 13,790,294.0000 | -8,421,179.0000 | -2,380,177.0000 | 5,640,954.0000 | 35,655,054.0000 | Jul 14, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
45/100
Profitability20
Growth66
Balance sheet0
Cash generation41
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $16M | Apr 1, 2025 – Mar 31, 2026 | Jul 14, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $13.79M | Apr 1, 2024 – Mar 31, 2025 | Jul 14, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$2.4M | Apr 1, 2025 – Mar 31, 2026 | Jul 14, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$718.96K | Apr 1, 2025 – Mar 31, 2026 | Jul 14, 2026 | 10-K |
| Total assetsAssets | $6.45M | Mar 31, 2026 | Jul 14, 2026 | 10-K |
| Total liabilitiesLiabilities | $39.41M | Mar 31, 2026 | Jul 14, 2026 | 10-K |